SCHEMBL20181897

SCHEMBL20181897

COc1cc(-c2cn(Cc3cn(-c4ccccc4F)nn3)c3ncnc(N)c23)ccc1N

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 10/20 0.42
RIPK2 O43353 1/20 0.41
ABL1 P00519 7/20 0.41
EGFR P00533 7/20 0.41
KDR P35968 4/20 0.41
LCK P06239 3/20 0.41
PIK3CD O00329 3/20 0.41
HCK P08631 2/20 0.41
PIK3CA P42336 2/20 0.41
PIK3CB P42338 2/20 0.41
MTOR P42345 2/20 0.41
PIK3CG P48736 2/20 0.41
EPHB4 P54760 2/20 0.41
PRKDC P78527 2/20 0.41
PI4KB Q9UBF8 2/20 0.41
TEK Q02763 2/20 0.41
CFTR P13569 2/20 0.40
CA2 P00918 1/20 0.40
CA5A P35218 1/20 0.40
CA9 Q16790 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20173318 0.90 TEK (0.41) SRCRIPK2ABL1EGFRKDR
SCHEMBL20173321 0.88 SRC (0.52) SRCRIPK2ABL1EGFRKDR
SCHEMBL20162676 0.87 CFTR (0.41) SRCRIPK2ABL1EGFRKDR
SCHEMBL30037245 0.87 CFTR (0.41) SRCRIPK2ABL1EGFRKDR
SCHEMBL20162596 0.85 PTGS2 (0.45) SRCCFTRCA2CA5ACA9
SCHEMBL30037644 0.85 PTGS2 (0.45) SRCCFTRCA2CA5ACA9
SCHEMBL20173314 0.85 CFTR (0.40) SRCCFTRCA2CA5ACA9
SCHEMBL20162830 0.84 SRC (0.41) SRCKDRLCKTEKCFTR
SCHEMBL20175298 0.83 SRC (0.42) SRCRIPK2ABL1EGFRKDR
SCHEMBL23481428 0.82 EIF2AK3 (0.41) SRCRIPK2ABL1LCKHCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018094137-A1 PYRROLOPYRIMIDINES AS CFTR POTENTIATORS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC. (US) 2018-05-24 WO disclosed